Facebook Redirects Users Searching for Opioids to Federal Crisis Help Line

Tech giants are grappling with questions about illicit sales on their platforms

Join Our Community of Science Lovers!

Facebook users attempting to purchase opioids or seeking out addiction treatment will be instead be redirected to information about a federal crisis help line, the company announced Tuesday, a major step for an industry leader facing pressure to more aggressively police illicit drug sales on its platform.

The announcement comes a week before an “opioids summit” convened by the Food and Drug Administration to get Facebook and other tech companies, including Twitter and Google, to take additional measures to help curb the nation’s opioid crisis.

The Facebook feature, the company said, is the result of months of work with a policy team largely focused on how the company can address the opioid epidemic—work that it said predates FDA Commissioner Scott Gottlieb’s focus on tech companies’ role in opioids issues.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Kevin Martin, who leads Facebook’s operation in Washington, announced the new feature at a Tuesday event, and the company recently added Avra Siegel, an Obama administration veteran, to lead the opioids policy initiative.

Siegel said the redirect feature—which will go live at some point Tuesday—was specific to Facebook, but planned in consultation with the recovery advocacy group Facing Addiction and the Substance Abuse and Mental Health Services Administration.

Greg Williams, the vice president at Facing Addiction, said Facebook aimed to seize on moments of vulnerability—searches either for treatment or for opportunities to purchase illicit drugs—to nudge individuals with opioid use disorder toward treatment.

Facebook’s efforts to stem the opioid epidemic come as part of a broader conversation about how much responsibility tech companies bear for illicit activity to take place on their platforms.

Republished with permission from STAT. This article originally appeared on June 19, 2018

STAT delivers fast, deep, and tough-minded journalism. We take you inside science labs and hospitals, biotech boardrooms, and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all.

More by STAT

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe